Twenty-four hours after ketamine administration, around the time of peak antidepressant response, a 1 H-MRS study in MDD found no significant changes in glutamatergic measures in the ACC 14
Slepnev VI, Ochoa GC, Butler MH, Grabs D, De Camilli P (1998)
Clinically used in oncology support protocols to reduce oxidative stress, aid recovery, and support immune function during and after treatment
Disorders Associated With Celiac Disease Type of disorder Disorder Endocrine Type 1 diabetes Autoimmune thyroiditis Adrenal insufficiency Sjgren syndrome Rheumatoid arthritis Systemic lupus erythematosus IgA deficiency Inflammatory bowel disease Microscopic colitis AIH, PSC, PBC Epilepsy IgA mesangial nephropathy Carditis Fibrosing alveolitis Pulmonary hemosiderosis Down syndrome, Turner syndrome Connective tissue disorders Immunologic Inflammatory conditions Hepatic Neurologic Kidney Cardiopulmonary Other Abbreviations: AIH, autoimmune hepatitis